Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Graft Failure”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Testing effectiveness (Phase 2)Looking for participantsNCT06753916
What this trial is testing

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

Who this might be right for
Corneal Transplant Failure
Massachusetts Eye and Ear Infirmary 96
Not applicableLooking for participantsNCT05775432
What this trial is testing

Prognosis of Heart Transplanted Patients With Heart Failure

Who this might be right for
Heart Failure
First Affiliated Hospital Xi'an Jiaotong University 1,000
Not applicableLooking for participantsNCT06895070
What this trial is testing

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

Who this might be right for
Heart TransplantHeart FailureTransplant; Failure, Heart
XVIVO Perfusion 60
Large-scale testing (Phase 3)Study completedNCT00042081
What this trial is testing

Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures

Who this might be right for
Coronary Artery Disease
Anesiva, Inc. 3,000
Testing effectiveness (Phase 2)Study completedNCT01996826
What this trial is testing

A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

Who this might be right for
Corneal NeovascularizationCorneal Graft Failure
Reza Dana, MD 75
Testing effectiveness (Phase 2)Ended earlyNCT00086164
What this trial is testing

Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis

Who this might be right for
HyperplasiaChronic Renal Failure
Anesiva, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Not applicableStudy completedNCT02649946
What this trial is testing

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft

Who this might be right for
StenosisRestenosis
C. R. Bard 280
Large-scale testing (Phase 3)Study completedNCT00041925
What this trial is testing

Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures

Who this might be right for
Peripheral Vascular DiseasesArterial Occlusive DiseasesIschemia+2 more
Anesiva, Inc. 1,400
Testing effectiveness (Phase 2)Study completedNCT05027074
What this trial is testing

Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)

Who this might be right for
End-Stage Renal DiseaseEnd-Stage Kidney DiseaseKidney Failure, Chronic
Merck Sharp & Dohme LLC 506
Not applicableWithdrawnNCT04951934
What this trial is testing

Prospective Randomized International Study on the Reactivation of Burn Injuries

Who this might be right for
BurnsSkin Graft (Allograft)(Autograft) Failure
Emoled
Not applicableLooking for participantsNCT04014413
What this trial is testing

Safety and Efficacy of Fecal Microbiota Transplantation

Who this might be right for
Crohn DiseaseUlcerative ColitisCeliac Disease+24 more
Chinese University of Hong Kong 450
Early research (Phase 1)Study completedNCT00062621
What this trial is testing

Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure

Who this might be right for
Kidney Failure, ChronicMultiple Myeloma
National Institute of Allergy and Infectious Diseases (NIAID) 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03192397
What this trial is testing

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in Complete RemissionChronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission+10 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT03370887
What this trial is testing

AZD8601 Study in CABG Patients

Who this might be right for
Heart Failure
AstraZeneca 11
Not applicableUnknownNCT02922088
What this trial is testing

EU Multicenter Registry to Assess Outcomes in CABG Patients: Treatment of Vascular Conduits With DuraGraft [VASC]

Who this might be right for
Cardiovascular DiseasesCoronary Artery Disease
Somahlution LLC 2,964
Early research (Phase 1)Study completedNCT02960646
What this trial is testing

Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome+13 more
M.D. Anderson Cancer Center 11
Large-scale testing (Phase 3)Study completedNCT03829488
What this trial is testing

Better Evidence for Selecting Transplant Fluids

Who this might be right for
End Stage Kidney DiseaseDelayed Graft FunctionKidney Transplant; Complications
The University of Queensland 808
Large-scale testing (Phase 3)Study completedNCT00755040
What this trial is testing

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Vanderbilt-Ingram Cancer Center 164
Large-scale testing (Phase 3)Ended earlyNCT00450333
What this trial is testing

Dynepo Infrequent Dosing Study

Who this might be right for
AnemiaKidney Failure
Shire 407
Load More Results
35